Photoelectron sells Intrabeam system to Poland:
This article was originally published in Clinica
Photoelectron has sold an Intrabeam system to the Instytut im Maril Sklodowskiej Curie neurological centre in Poland. The product is used for the interstitial treatment of brain tumours, as well as for the delivery of intraoperative radiation therapy in the treatment of brain tumours and breast cancers, the Lexington, Massachusetts-based company says. The deal was carried out by Photoelectron's distributor, Carl Zeiss.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.